Manulife (Manufacturers Life Insurance)’s Y-mAbs Therapeutics YMAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-13,143
| Closed | -$59.3K | – | 3004 |
|
|
2025
Q2 | $59.3K | Sell |
13,143
-796
| -6% | -$3.58K | ﹤0.01% | 2864 |
|
|
2025
Q1 | $61.8K | Buy |
13,939
+121
| +0.9% | +$702 | ﹤0.01% | 2800 |
|
|
2024
Q4 | $108K | Sell |
13,818
-268
| -2% | -$3.26K | ﹤0.01% | 2803 |
|
|
2024
Q3 | $185K | Sell |
14,086
-336
| -2% | -$4.26K | ﹤0.01% | 2696 |
|
|
2024
Q2 | $174K | Sell |
14,422
-253
| -2% | -$3.42K | ﹤0.01% | 2655 |
|
|
2024
Q1 | $239K | Sell |
14,675
-907
| -6% | -$12.2K | ﹤0.01% | 2515 |
|
|
2023
Q4 | $106K | Hold |
15,582
| – | – | ﹤0.01% | 2798 |
|
|
2023
Q3 | $84.9K | Hold |
15,582
| – | – | ﹤0.01% | 2857 |
|
|
2023
Q2 | $106K | Sell |
15,582
-532
| -3% | -$3.99K | ﹤0.01% | 2828 |
|
|
2023
Q1 | $80.7K | Hold |
16,114
| – | – | ﹤0.01% | 2787 |
|
|
2022
Q4 | $78.6K | Buy |
16,114
+1,371
| +9% | +$9.96K | ﹤0.01% | 2853 |
|
|
2022
Q3 | $213K | Sell |
14,743
-332
| -2% | -$5.5K | ﹤0.01% | 2554 |
|
|
2022
Q2 | $228K | Sell |
15,075
-240
| -2% | -$2.8K | ﹤0.01% | 2571 |
|
|
2022
Q1 | $182K | Sell |
15,315
-3,905
| -20% | -$40.1K | ﹤0.01% | 2809 |
|
|
2021
Q4 | $312 | Buy |
19,220
+364
| +2% | +$7.78K | ﹤0.01% | 2585 |
|
|
2021
Q3 | $538K | Sell |
18,856
-1,341
| -7% | -$42.3K | ﹤0.01% | 2237 |
|
|
2021
Q2 | $683K | Buy |
20,197
+2,412
| +14% | +$77.4K | ﹤0.01% | 2219 |
|
|
2021
Q1 | $538K | Sell |
17,785
-788
| -4% | -$32.3K | ﹤0.01% | 2223 |
|
|
2020
Q4 | $920K | Buy |
18,573
+733
| +4% | +$33.9K | ﹤0.01% | 1872 |
|
|
2020
Q3 | $685K | Sell |
17,840
-287
| -2% | -$11.4K | ﹤0.01% | 1841 |
|
|
2020
Q2 | $828K | Buy |
18,127
+2,774
| +18% | +$105K | ﹤0.01% | 1709 |
|
|
2020
Q1 | $401K | Buy |
15,353
+2,485
| +19% | +$72.1K | ﹤0.01% | 1935 |
|
|
2019
Q4 | $402K | Sell |
12,868
-599
| -4% | -$17.7K | ﹤0.01% | 2178 |
|
|
2019
Q3 | $347K | Buy |
13,467
+378
| +3% | +$9.66K | ﹤0.01% | 2235 |
|
|
2019
Q2 | $299K | Buy |
+13,089
| New | +$301K | ﹤0.01% | 2367 |
|
Other funds holding YMAB
Manulife (Manufacturers Life Insurance)'s YMAB Position: Q3 2025 in Review
Manulife (Manufacturers Life Insurance) sold out of Y-mAbs Therapeutics (YMAB) in Q3 2025, closing a stake of 13,143 shares — an estimated $59.3K sold.
Manulife (Manufacturers Life Insurance) first reported a position in YMAB in Q2 2019 and held it in 25 quarters. The position peaked at $920K in Q4 2020. 2 funds tracked by Wall St. Rank hold YMAB as of Q3 2025.
- Manulife (Manufacturers Life Insurance) reported no remaining Y-mAbs Therapeutics position as of Q3 2025 after selling out during the quarter.
- Manulife (Manufacturers Life Insurance) sold 13,143 Y-mAbs Therapeutics shares in Q3 2025, an estimated $59.3K.
- Manulife (Manufacturers Life Insurance) first reported a position in Y-mAbs Therapeutics in Q2 2019 and held it in 25 quarters.
- Manulife (Manufacturers Life Insurance)'s Y-mAbs Therapeutics position peaked at $920K in Q4 2020.
- 2 funds tracked by Wall St. Rank held Y-mAbs Therapeutics as of Q3 2025.
Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q3 2025, filed 14 Nov 2025.